Biography
Prof. Hijazi has nearly 40 years of experience in Congenital Cardiology and has pioneered several groundbreaking Interventional procedures in the field. He is an internationally recognized leader in the nonsurgical repair of congenital and structural heart defects in children and adults and in the development of novel transcatheter devices. As CMO of Sidra Medicine, Prof. Hijazi will be responsible for the overall management of the hospitals Medical operations, upholding its clinical excellence and patient safety programs and ensuring that patients in Qatar receive the highest standard of medical care.
Track Chairs:
Sharon Terry, Genetic Alliance & Alice Rathjen
Qatar Foundation’s Sidra Medicine is a leading regional research hospital and tertiary care facility for women and children, seeing nearly 200,000 patients in 2020. This session will explore the work at Sidra Medicine to take from bench to bedside the applications arising from newly analysed datasets of the Arab genome that will have benefits for patient care, pharmacogenomics and population health.